Pseudoginsenoside Rh2
Pseudoginsenoside Rh2, synthesized from Ginsenoside Rh2, possesses anti-cancer activitied[1].
Product Specifications
CAS Number
1370264-16-6
UNSPSC
12352005
Target
Drug Derivative
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pseudoginsenoside-rh2.html
Solubility
10 mM in DMSO
Smiles
C[C@]12[C@@](C[C@H]([C@@]3([H])[C@]2(CC[C@@H]3/C(C)=C/CCC(C)(O)C)C)O)([H])[C@@]4([C@@](C(C)([C@H](CC4)O[C@@H]5O[C@@H]([C@H]([C@@H]([C@H]5O)O)O)CO)C)([H])CC1)C
Molecular Formula
C36H62O8
Molecular Weight
622.87
References & Citations
[1]Qian G, et al. Synthesis and anti-cancer cell activity of pseudo-ginsenoside Rh2. Steroids. 2014 Dec;92:1-6.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC882609-100 1x 100 µL
NRF1 (NRF1/2609), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC882047-100 1x 100 µL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2047), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400245-500 1x 500 µL
SHBG (Sex Hormone Binding Globulin) (SHBG/245), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details